CTOs on the Move

Annexon Biosciences

www.annexonbio.com

 
Annexon is a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders of the body, brain and eye. The company`s pipeline is based on its platform technology addressing a broad spectrum of well-researched classical complement-mediated autoimmune and neurodegenerative diseases triggered by aberrant activation of C1q, the initiating molecule of the classical complement pathway. Annexon is advancing a portfolio of innovative product candidates designed to block the activity of C1q and the entire classical complement pathway: ANX005 (intravenous administration), ANX007 (intravitreal administration) and ANX009 (subcutaneous administration). Annexon is deploying a ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.annexonbio.com
  • 180 Kimball Way 2nd Floor, Suite 200
    South San Francisco, CA USA 94080
  • Phone: 650.822.5500

Executives

Name Title Contact Details
David Green
VP, Head of IT Profile
Ted Yednock
Executive Vice President and Chief Innovation Officer Profile

Funding

Annexon Biosciences raised $44M on 06/24/2016
Annexon Biosciences raised $75M on 12/19/2018

Similar Companies

Opus Genetics

Opus Genetics is a groundbreaking gene therapy company for inherited retinal diseases with a unique model and purpose. Backed by Foundation Fighting Blindness`s venture arm, the RD Fund, Opus combines unparalleled insight and commitment to patient need with wholly owned programs in numerous orphan retinal diseases.

Joyn Bio

Probiotics for Plants, We design microbes for more sustainable agriculture.

BiomedAIliance

BiomedAIliance is a Palo Alto, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pharmative

Pharmative is a Northridge, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pattern Bioscience

Pattern is building a dream team of scientists and visionaries dedicated to addressing this global problem with faster, smarter diagnostics for more precise treatment.